Prognostic value of programmed death ligand 1, p53, and Ki-67 in patients with advanced stage colorectal cancer [PDF]
, 2017 Current prognostic indicators are ineffective for identifying advanced stage colorectal cancer (CRC) patients with high risk of recurrence after surgical resection. We investigated the prognostic value of p53, Ki-67, and programmed death ligand 1 (PD-L1)
Baldridge, Lee A. +8 more
core +1 more source
Determination of Ki-67 defined growth fraction by monoclonal antibody MIB- I in formalin-fixed, paraffin-embedded prostatic cancer tissues [PDF]
, 1995 The applicability of MIB‐1, a monoclonal antibody directed against the Ki‐67 antigen, was studied in the PC‐82 and LNCaP prostatic tumor models at various levels of proliferative activity.
Kwast, Th.H. (Theo) van der +5 more
core +1 more source
Journal of Translational Medicine, 2023 Background and purpose Ki-67 labeling index (LI) is an important indicator of tumor cell proliferation in glioma, which can only be obtained by postoperative biopsy at present.
Ningfang Du +10 more
doaj +1 more source
Asian Pacific Journal of Cancer Biology, 2022 Background: CDX2 has been established as a good prognostic marker for colorectal carcinomas. Differentiated adenocarcinomas are characterized by higher CDX2 expression than undifferentiated tumors with stronger reactivity in intestinal phenotypes.
Chatpalli Pranjali +2 more
doaj +1 more source
The nucleolar protein NIFK promotes cancer progression via CK1α/β-catenin in metastasis and Ki-67-dependent cell proliferation. [PDF]
, 2016 Nucleolar protein interacting with the FHA domain of pKi-67 (NIFK) is a Ki-67-interacting protein. However, its precise function in cancer remains largely uninvestigated.
Chang, Hong-Tai +17 more
core +2 more sources
Thoracic Cancer, 2019 Background The Ki‐67 labeling index (LI) is a well‐known prognostic factor for primary breast cancer, but its clinical significance for metachronous axillary lymph node (ALN) recurrence has not been well documented.
Naoya Ishibashi +7 more
doaj +1 more source
The prognostic and predictive potential of Ki-67 in triple-negative breast cancer
Scientific Reports, 2020 As a cell proliferation biomarker, Ki-67 is principally used in ER+/HER2− breast cancer. However, the importance and the best cutoff point of Ki-67 in triple-negative breast cancer (TNBC) remains unclear and was evaluated in this study.A total of 1800 ...
Xiuzhi Zhu +10 more
semanticscholar +1 more source
The time-dependent localization of Ki 67 antigen-positive cells in human skin wounds [PDF]
, 1993 A total of 77 human skin wounds with a post-infliction interval between 3 h and 7 months were investigated and the proliferation marker antigen Ki 67 was visualized in paraffin sections using a specific monoclonal antibody (MIB).
A. Nerlich +22 more
core +1 more source
Immunoexpression of Ki-67 and endoglin corroborating hamartomatous nature of sialoangiolipoma
Contemporary Clinical Dentistry, 2017 Mesenchymal neoplasms of salivary gland including adipocytes are relatively uncommon entity classified as monophasic and biphasic. Sialolipoma, a biphasic mesenchymal salivary gland neoplasm, with a prominent vascularity designated as sialoangiolipoma ...
Swagatika Panda +4 more
doaj +1 more source
Effect of inosine pranobex on p16, Ki-67 expression in patients with HPV-associated cervical intraepithelial neoplasia [PDF]
Гинекология, 2018 The aim of the study - to determine the dynamics of expression of р16, Ki-67 in patients with HPV-associated cervical intraepithelial neoplasia (CIN) in the complex treatment with inosine pranobex. Materials and methods.
T V Klinyshkova, O N Mironova
doaj +1 more source